Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric H Yang

Showing results (21-30 of 240) with videos related to

Pageof 24
Sort By:
Future Oncology (London, England)|July 23, 2015
Should vascular effects of newer treatments be addressed more completely?Eric H Yang, Karol E Watson, Joerg Herrmann
European Journal of Preventive Cardiology|February 24, 2021
Linear reverse risk of HDL-C levels for predicting cardiovascular disease: it is not that straightforward!Ragavendra R Baliga, Eric H Yang, Eduardo Bossone
Current Oncology Reports|May 29, 2020
The COVID-19 Pandemic and its Impact on the Cardio-Oncology PopulationIshan Asokan, Soniya V Rabadia, Eric H Yang
Journal of the American College of Cardiology|December 4, 2010
A superinfected pulmonary valve myxomaEric H Yang, Andrew A Zadeh, Jina Chung
The American Journal of Medicine|March 27, 2012
Digitalis toxicity: a fading but crucial complication to recognizeEric H Yang, Sonia Shah, John M Criley
JACC. Cardiooncology|January 17, 2026
Defining the Name of the Game in Exercise Oncology: How Do We Incentivize Physical Activity?Enat Arega, Christina M Dieli-Conwright, Eric H Yang
Journal of the American Heart Association|December 16, 2021
Inequity in Cardio-Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer OutcomesRachel E Ohman, Eric H Yang, Melissa L Abel
Annals of Internal Medicine|October 18, 2006
Narrative review: reperfusion strategies for ST-segment elevation myocardial infarctionHenry H Ting, Eric H Yang, Charanjit S Rihal
Heart Failure Clinics|June 19, 2022
T-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager TherapiesAshley F Stein-Merlob, Sarju Ganatra, Eric H Yang
Circulation|November 25, 2016
Response by Herrmann et al to Letter Regarding Article, "Vascular Toxicities of Cancer Therapies: The Old and the New-An Evolving Avenue"Joerg Herrmann, Eric H Yang, Cezar Iliescu, et al.
Pageof 24

Showing results (21-30 of 240) with videos related to

Sort By:
Pageof 24
Future Oncology (London, England)|July 23, 2015
Should vascular effects of newer treatments be addressed more completely?Eric H Yang, Karol E Watson, Joerg Herrmann
European Journal of Preventive Cardiology|February 24, 2021
Linear reverse risk of HDL-C levels for predicting cardiovascular disease: it is not that straightforward!Ragavendra R Baliga, Eric H Yang, Eduardo Bossone
Current Oncology Reports|May 29, 2020
The COVID-19 Pandemic and its Impact on the Cardio-Oncology PopulationIshan Asokan, Soniya V Rabadia, Eric H Yang
Journal of the American College of Cardiology|December 4, 2010
A superinfected pulmonary valve myxomaEric H Yang, Andrew A Zadeh, Jina Chung
The American Journal of Medicine|March 27, 2012
Digitalis toxicity: a fading but crucial complication to recognizeEric H Yang, Sonia Shah, John M Criley
JACC. Cardiooncology|January 17, 2026
Defining the Name of the Game in Exercise Oncology: How Do We Incentivize Physical Activity?Enat Arega, Christina M Dieli-Conwright, Eric H Yang
Journal of the American Heart Association|December 16, 2021
Inequity in Cardio-Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer OutcomesRachel E Ohman, Eric H Yang, Melissa L Abel
Annals of Internal Medicine|October 18, 2006
Narrative review: reperfusion strategies for ST-segment elevation myocardial infarctionHenry H Ting, Eric H Yang, Charanjit S Rihal
Heart Failure Clinics|June 19, 2022
T-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager TherapiesAshley F Stein-Merlob, Sarju Ganatra, Eric H Yang
Circulation|November 25, 2016
Response by Herrmann et al to Letter Regarding Article, "Vascular Toxicities of Cancer Therapies: The Old and the New-An Evolving Avenue"Joerg Herrmann, Eric H Yang, Cezar Iliescu, et al.
Pageof 24